According to Nova One Advisor, the global exosome research market size is calculated at USD 225.72 million in 2025 and is ...

Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence ...

By restructuring a common chemotherapy drug, scientists increased its potency by 20,000 times. In a significant step forward ...

HAYWARD, Calif., Nov. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based ...

Challenging a long-standing assumption regarding the adult brain, recent research has demonstrated that individuals can ...

The company is known for its products that enable customers to gain valuable insights from the building blocks of life, such as DNA, RNA, and proteins. Average Trading Volume: 1,250,489 Technical ...

Dilated cardiomyopathy (DCM), a leading cause of heart failure, is twice as common in Black individuals as in white ...

A team of scientists has developed a highly accurate blood test for Chronic Fatigue Syndrome. The test reads tiny DNA patterns that reveal the biological signature of the illness. For millions who’ve ...

Silkworm hibernation, called diapause, is triggered by hormones. New research pinpointed an enzyme, BmSdh2, as key to maintaining this dormant state.